Knowles Corporation's top executive has sold a significant portion of his holdings, a move that comes on the heels of a 24% annual gain for the audio components maker and ahead of its upcoming earnings report.
With the Federal Reserve holding rates steady and economic signals mixed, investors are looking beyond the S&P 500 for growth. We analyze three under-the-radar companies—Tiptree, Slide Insurance, and Colony Bankcorp—that show strong fundamentals and strategic momentum as we head into 2026.
Investors who backed wind turbine manufacturer Nordex SE (ETR:NDX1) twelve months ago have seen their holdings nearly triple in value, with shares skyrocketing 197%. The surge highlights a powerful rally in renewable energy stocks amid favorable policy shifts and strong order books.
LPL Financial Holdings Inc. (LPLA) reported robust fourth-quarter results, reaching a milestone $2.4 trillion in advisory and brokerage assets. Adjusted earnings per share grew 23%, driven by strategic execution and the integration of Commonwealth Financial.
Axis Capital (AXS) reported robust 2025 results, marked by record premiums and its best underwriting performance in over a decade. While outlining a confident growth trajectory, executives struck a cautious note on cyber insurance and reinsurance headwinds for the coming year.
While the broader ASX has climbed nearly 10% over the past year, shareholders of cloud accounting giant Xero have watched their holdings plummet by 47%. This stark divergence raises questions about market sentiment versus the company's underlying performance, which shows surprising resilience.
Vera Therapeutics appoints industry veteran Matt Skelton as Chief Commercial Officer, signaling a strategic pivot toward commercialization as its lead drug candidate for IgA nephropathy, atacicept, undergoes FDA Priority Review.
Vertiv's launch of its 'Next Predict' AI service aims to transform data center maintenance. While it strengthens the company's AI infrastructure narrative, investors are weighing rich valuations against execution risks in a maturing growth cycle.
The operator of KFC and Pizza Hut in China reports quarterly results Wednesday, with investors watching for signs of sustained recovery in a competitive dining landscape.
As the RBA's policy decisions loom, investors are scouring the market for resilient opportunities. We spotlight three ASX-listed penny stocks—Aura Energy, Beam Communications, and Count Limited—each with a market cap over A$10 million, offering a blend of high-risk potential and strategic positioning in their respective sectors.
Bunge Global SA (NYSE:BG) is set to release its quarterly earnings Wednesday morning, with investors keen to see if the agribusiness leader can sustain its momentum amid shifting commodity markets and analyst skepticism.
Central Garden & Pet (CENT) is scheduled to release its fourth-quarter financial results after Wednesday's market close, with Wall Street anticipating a year-over-year revenue decline. The report comes as the broader household products sector shows investor optimism.
As Lucky Strike (NYSE:LUCK) prepares to release its Q4 results, investors are weighing its recent outperformance against a history of revenue misses and a slumping stock price. Here's the breakdown ahead of the bell.
Despite stellar fundamentals and a dominant market position, Mastercard's premium valuation is prompting a debate among investors. While bulls champion its profitability and growth, skeptics warn of overextension, suggesting a pullback may offer a more attractive entry point.
After Abbott Laboratories' stock plunged nearly 10% on disappointing revenue, CEO Robert B. Ford made a significant personal investment, purchasing $2 million in company shares. This move, seen as a strong signal of insider confidence, highlights a clash between short-term market jitters and long-term corporate strategy.
MINISO Group Holding Ltd. (NYSE: MNSO) is capturing investor attention with a potent mix of rapid global store expansion, surging revenue from its TOP TOY brand, and robust cash generation. The company's latest earnings reveal a strategic pivot paying off, even as it navigates the competitive global retail landscape.
Twist Bioscience's proprietary silicon-based DNA manufacturing platform is driving double-digit revenue growth and margin expansion, positioning the synthetic biology tools provider on a clear path to adjusted EBITDA breakeven by fiscal 2026.
Despite facing near-term pressures from a softer ad market and intensified competition, The Trade Desk's leadership in programmatic advertising and its scalable platform present a compelling case for patient investors eyeing the sector's structural shift.
Specialist asset manager Cohen & Steers (NYSE: CNS) is attracting bullish attention as its focus on real assets aligns with a shifting monetary policy landscape. After a prolonged period of outflows, the firm is seeing renewed investor interest.
Cronos Group's stock has rallied on renewed optimism for U.S. cannabis reform. We examine the regulatory shift, strategic positioning, and long-term potential driving investor sentiment.
